News and Comments

What Could Happen To HGSI’s SLE Drug On Tuesday?

  Monday, November 15, 2010

A few days before the independent FDA committee review of Human Genome Sciences’ (HGSI) systemic lupus erythematosus (SLE) drug Benlysta (belimumab), the FDA suggested that the drug has marginal efficacy and scary adverse effects. The agency expressed concerns about infection, neuropsychiatric complications, including the risk of suicide, and increased risk of death as a result of the use of the drug. The FDA message to the independent committee, which will convene on Tuesday, is to decide whether the reward is worth the high risk. The FDA has also observed that studies conducted outside the U.S. produced stronger data than the U.S.; these studies were not consistent with the U.S. results. The agency has also observed that the African-American lupus patients had benefited less from Benlysta than did non-African American patients.  More...


Recent Postings


Archive


Tags

KERYX (KERX) Aimmune Therapeutics (AIMT) IDERA (IDRA) Theravance (THRX) C4 Therapeutics Anacor (ANAC) Inovio (INO) Agenus (AGEN) ACADIA (ACAD) Endometrial Cancer SYNTA (SNTA) RenenxBio (RGNX) BIOMARIN (BMRN) Auspex (ASPX) Prosensa (RNA) Revlimid (lenolidamide) Benlysta (belimumab) VANDA (VNDA) Sangamo (SGMO) KITE (KITE) Multiple Myeloma Biocryst (BCRX) Valeant Pharmaceuticals International (VRX) Ionis (IONS) Alnylam (ALNY) AERIE PHARMACEUTICALS PTC Therapeutics (PTCT) ImmunoGen (IMGN) NANTKWEST (NK) Herceptin Roche (RHHBY) Intermune (ITMN) SUNESIS PHARMACEUTICALS (SNSS) Ridaforolimus Sanofi (SNA) Amgen (AMGN) Incyte (INCY) ADVENTRIX (ANX) Human Genome Sciences (HGSI) Sequenom (SQNM) Zerenex Genentech Editas (EDIT) REGULUS (RGLS) Spike Therapeutics (ONCE) TOKAI (TKAOI) Telaprevir Vitae Pharmaceuticals (VTAE) INNOVIVA (INVA) ZALTRAP™ Rapamune Velcade (bortezomib) Dynavax (DVAX) Ariad (ARIA) Illumina (ILMN) Pluristem (PSTI) Trastuzumab-DM1 CompuGen (CGEN) Tysabri OSI (OSIP) ARCA (ABIO) Ziofpharm (ZIOP) Seattle Genetics (SGEN) Sanofi-Aventis (SAN) Agenus (AGEN Onyx (ONXX) galapagos (GLPG) Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) JUNO (JUNO) GUARDIAN HEALTH ISIS (ISIS) Idenix (IDIX) Exelixis (EXEL) Xoma (XOMA) Galena (GALE) NEKTAR (NKTR)) Prolor Biotech (PBTH) ABBVIE (ABBV) Dendreon (DNDN) SERES THERAPEUTICS (MCRB) Sanofi (SNY) Abbott Laboratories (ABT) Global Cell Therapeutics (GBT) Mirati Therapeutics (MRTX) Theravance Bio Pharma (TBPH) Regeneron (REGN) AGOS (ARGS) Human Longevity (HLI) Gilead (GILD) Merck (MRK) Roche (ROCHE) Micromet (MITI) Elan (ELN) Alder Biopharmaceuticals (ALDR) Vertex (VRTX) ARGOS (ARGS) GlaxoSmithKline (GSK) Intrexon (XON) HALOZYME (HALO) Array Pharmaceuticals (ARRY) Bristol-Myers Squibb (BMY) Cytokinetics (CYTK) Biogen Idec (BIIB) Anadys (ANDS) Intercept (ICPT)